Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2018-07
-
HATU in Peptide Synthesis: Strategic Selection and Assay Imp
2026-05-25
Explore the advanced role of HATU in peptide synthesis chemistry, with a focus on strategic reagent selection, mechanistic insight, and assay optimization. This article delivers unique guidance on applying HATU, grounded in recent research and practical protocols.
-
Z-WEHD-FMK: Precision Caspase Inhibition in Inflammation Res
2026-05-24
Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) empowers researchers to dissect caspase-driven pathways with unmatched specificity, enabling reproducible results in inflammation, apoptosis, and microbial pathogenesis studies. Discover protocol enhancements, troubleshooting strategies, and data-driven insights to maximize the impact of this irreversible caspase-1/4/5 inhibitor.
-
VX-765: Selective Caspase-1 Inhibition for Pyroptosis Resear
2026-05-23
VX-765 unlocks precision control over inflammasome-driven cell death and cytokine release, uniquely enabling robust, reproducible workflows in inflammation and infectious disease research. Its high selectivity for caspase-1 and oral bioavailability set a new benchmark for dissecting IL-1β and IL-18–dependent pathways in both myeloid and lymphoid contexts.
-
DGLA-Induced Ferroptosis via ACSL4 in AML: Metabolic Reprogr
2026-05-22
This study demonstrates that exogenous dihomo-γ-linolenic acid (DGLA) induces ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings highlight the therapeutic potential of targeting lipid metabolism to overcome chemoresistance in AML.
-
Z-VAD-FMK: Redefining Apoptosis Research for Translational I
2026-05-22
This thought-leadership article explores how Z-VAD-FMK, an irreversible pan-caspase inhibitor from APExBIO, is catalyzing the next era of apoptosis and cell death pathway research. By blending fresh mechanistic insights with strategic guidance, we map out how translational researchers can leverage Z-VAD-FMK to dissect caspase-dependent and -independent cell death, inform clinical workflows, and address emerging challenges in cancer and antiviral research, drawing on the latest evidence—including new findings on poxvirus-driven necroptosis.
-
LY2109761: Dual TGF-β Receptor Inhibitor for Tumor Research
2026-05-21
LY2109761 is a potent TGF-β receptor type I and II dual inhibitor that blocks Smad2/3 phosphorylation and demonstrates robust anti-tumor and anti-fibrotic activity in preclinical models. Its selectivity and nanomolar potency make it a benchmark tool for modulating TGF-β signaling in oncology and fibrosis research.
-
Z-WEHD-FMK: Precision Inhibition for Inflammation Research
2026-05-21
Z-WEHD-FMK (Z-Trp-Glu(OMe)-His-Asp(OMe)-FMK) empowers researchers to dissect inflammatory and apoptotic pathways with unrivaled specificity and reproducibility. This guide delivers stepwise workflow strategies, protocol enhancements, and troubleshooting insights to maximize assay reliability in caspase signaling and infectious disease models.
-
3-Deazaneplanocin (DZNep): Applied Workflows and Troubleshoo
2026-05-20
3-Deazaneplanocin (DZNep) delivers robust epigenetic modulation for cancer and metabolic disease research, uniquely enabling apoptosis induction in AML cells and cancer stem cell targeting. This article translates advanced workflows and troubleshooting strategies to maximize data reproducibility using APExBIO’s DZNep.
-
Strategic Caspase-1 Inhibition: Z-YVAD-FMK in Translational
2026-05-20
This thought-leadership article explores the mechanistic foundation and strategic deployment of Z-YVAD-FMK as a best-in-class caspase-1 inhibitor for translational researchers. Integrating recent insights on HOXC8-mediated pyroptosis in cancer and the compound’s selectivity profile, we bridge advanced protocol design with practical guidance and future outlooks. This piece uniquely positions Z-YVAD-FMK not only as a critical tool for apoptosis, pyroptosis, and inflammasome activation studies, but as a strategic lever to dissect and modulate inflammatory cell death in cutting-edge disease models.
-
Methyl-β-cyclodextrin: Technical Use in Membrane Studies
2026-05-19
Methyl-β-cyclodextrin is a high-purity biochemical reagent optimized for extracting cholesterol and select lipids from cellular membranes, supporting research on membrane fluidity and lipid raft organization. It should not be used in diagnostic, clinical, or therapeutic workflows. This article provides protocol guidance, workflow quality control, and troubleshooting specific to research applications.
-
EdU Imaging Kits (Cy5): Advanced DNA Synthesis Measurement W
2026-05-19
EdU Imaging Kits (Cy5) offer a sensitive, morphology-preserving approach to quantifying cell proliferation, outperforming BrdU-based assays in both workflow efficiency and data quality. This article explores experimental strategies and troubleshooting tips, grounded in recent cancer biology research, to maximize the impact of your 5-ethynyl-2'-deoxyuridine imaging kit experiments.
-
Halazone: Antimicrobial Sulfonamide for Water and Ion Channe
2026-05-18
Halazone is a dual-function antimicrobial sulfonamide derivative, excelling as a rapid water disinfection agent and a precise modulator of neuronal sodium channels. Discover robust workflows, advanced assay design, and troubleshooting strategies that leverage Halazone’s unique chemical profile for both microbiology and neurophysiology research.
-
TPCA-1: Precision IKK-2 Inhibition for Renal Inflammation Mo
2026-05-18
Explore the scientific advances in using TPCA-1, a potent IKK-2 inhibitor, for dissecting NF-κB-driven inflammation in renal disease models. This article uniquely bridges molecular mechanism with translational assay design, offering actionable insights for inflammation research.
-
Sodium Ascorbate: Protocols and Troubleshooting in Glioblast
2026-05-17
Sodium Ascorbate, a mineral salt of ascorbic acid, is a powerful tool for inducing targeted necrotic death in tumor research models, notably glioblastoma. This guide presents experimentally validated workflows, advanced applications, and troubleshooting strategies to maximize reproducibility and scientific insight.
-
Acridine Orange hydrochloride: Practical Guide for Nucleic A
2026-05-16
Acridine Orange hydrochloride provides rapid, differential fluorescent staining of DNA and RNA for cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid assays. It is best suited for cytochemical workflows requiring precise discrimination of nucleic acids and should not be used for applications outside validated protocols or for long-term solution storage.